Physician profile
Frederick D Harris
NPI 1831147859
$10,643.03
in general payments reported to CMS, 2019-2025
45 companies · $604 in 2025
The $604 reported for 2025 was more than what 77% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,752 · 2020: $1,680 · 2021: $1,672 · 2022: $1,195 · 2023: $1,243 · 2024: $498 · 2025: $604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,344.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $2,353.26 | 2019-2023 | |
| Amgen INC. | $1,188.61 | 2019-2025 | Repatha, Repatha, Otezla |
| Astrazeneca Pharmaceuticals Lp | $1,036.40 | 2019-2023 | Breztri, Farxiga |
| Novo Nordisk INC | $959.77 | 2019-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $854.87 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Mylan Specialty L.P. | $560.93 | 2019-2020 | |
| Pfizer INC. | $478.83 | 2019-2023 | |
| Abbvie INC. | $384.64 | 2020-2022 | |
| Globus Medical, INC. | $217.42 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $204.18 | 2020-2023 | |
| Teva Pharmaceuticals USA, INC. | $198.26 | 2021-2023 | Airduo Digihaler |
| Abbott Laboratories | $182.05 | 2021-2024 | Freestyle Libre 3 |
| Olympus America INC. | $158.47 | 2025 | Itind System |
| Astellas Pharma US INC | $157.55 | 2019-2023 | Myrbetriq |
| Biohaven Pharmaceuticals, INC. | $153.70 | 2020-2021 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.